Bridgeway Capital Management, LLC Volitionrx LTD Transaction History

Bridgeway Capital Management, LLC

$4.76 Billion
Q1 2024

A detailed history of Bridgeway Capital Management, LLC transactions in Volitionrx LTD stock. As of the latest transaction made, Bridgeway Capital Management, LLC holds 174,180 shares of VNRX stock, worth $106,249. This represents 0.0% of its overall portfolio holdings.

Number of Shares

174,180

Previous 176,100 1.09%

Holding current value

$106,249

Previous $126,000 4.76%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.72 - $1.19 $1,382 - $2,284	-1,920 Reduced 1.09%	174,180 $132,000
Q1 2023 May 15, 2023	BUY	$1.54 - $2.68 $77,000 - $134,000	50,000 Added 39.65%	176,100 $336,000
Q3 2022 Nov 14, 2022	SELL	$1.57 - $2.38 $180,550 - $273,700	-115,000 Reduced 47.7%	126,100 $171,000
Q4 2021 Feb 14, 2022	SELL	$3.02 - $4.13 $75,500 - $103,250	-25,000 Reduced 9.39%	241,100 $757,000
Q3 2021 Nov 15, 2021	SELL	$2.98 - $3.48 $110,856 - $129,456	-37,200 Reduced 12.27%	266,100 $825,000

Q2 2021 Aug 16, 2021	SELL	$3.01 - $3.78 $387,688 - $486,864	-128,800 Reduced 29.81%	303,300 $998,000
Q1 2021 May 17, 2021	BUY	$3.33 - $6.5 $921,078 - $1.8 Million	276,600 Added 177.88%	432,100 $1.63 Million
Q4 2020 Feb 16, 2021	BUY	$2.88 - $4.33 $161,568 - $242,913	56,100 Added 56.44%	155,500 $605,000
Q2 2020 Aug 14, 2020	SELL	$2.89 - $4.32 $361,250 - $540,000	-125,000 Reduced 55.7%	99,400 $387,000
Q3 2018 Nov 13, 2018	BUY	$1.57 - $2.59 $39,250 - $64,750	25,000 Added 12.54%	224,400 $581,000
Q1 2018 May 15, 2018	BUY	$2.29 - $3.95 $206,100 - $355,500	90,000 Added 82.27%	199,400 $479,000
Q4 2017 Feb 14, 2018	BUY	$2.1 - $3.72 $229,740 - $406,968	109,400	109,400 $322,000

Others Institutions Holding VNRX

# of Institutions

Shares Held

7.96M

Call Options Held

39K

Put Options Held

View Full List

About VOLITIONRX LTD

Ticker VNRX
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 57,297,000
Market Cap $35M
Description
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose a range of cancers and other diseases worldwide. It sells Nu.Q that detect cancer; Nu.Q Nets, monitoring the immune system; Nu.Q Vet cancer screening test for veterinary applications; Nu.Q Capture capturing and concentrating sampl...

More about VNRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bridgeway Capital Management, LLC with notifications on news.

Account

Bridgeway Capital Management, LLC Volitionrx LTD Transaction History